Jazz Pharmaceuticals (JAZZ) Non Operating Income (2015 - 2017)
Jazz Pharmaceuticals' quarterly Non Operating Income came in at -$1.5 million in Q1 2017, down 78.75% year-on-year from -$6.9 million in Q1 2016, and down 95.46% quarter-over-quarter from -$749000.0 in Q3 2016.
Jazz Pharmaceuticals has reported Non Operating Income for 3 years, with the latest figure at -$1.5 million in Q1 2017.
- For the quarter ending Q1 2017, Non Operating Income fell 78.75% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2017 stood at -$3.0 million (down 87.28% YoY), and the FY2015 full-year result was $1.4 million, down 83.36% from the prior year.
- Non Operating Income for Q1 2017 stood at -$1.5 million, down from -$749000.0 in the prior quarter.
- The five-year high for Non Operating Income was $2.2 million in Q1 2015, with the low at -$1.9 million in Q2 2015.
- Average Non Operating Income over 3 years is -$226714.3, with a median of -$819000.0 recorded in 2016.
- Peak annual rise in Non Operating Income reached 23.34% in 2016, while the deepest fall reached 136.48% in 2016.
- Tracing JAZZ's Non Operating Income over 3 years: stood at $2.1 million in 2015, then plunged by 135.82% to -$749000.0 in 2016, then tumbled by 95.46% to -$1.5 million in 2017.
- The last three Non Operating Income figures came in at -$1.5 million (Q1 2017), -$749000.0 (Q3 2016), and -$819000.0 (Q1 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -1.46 Mn |
| Sep 30, 2016 | -749,000.00 |
| Mar 31, 2016 | -819,000.00 |
| Dec 31, 2015 | 2.09 Mn |
| Sep 30, 2015 | -977,000.00 |
| Jun 30, 2015 | -1.91 Mn |
| Mar 31, 2015 | 2.25 Mn |